A Retrospective, Multicenter study assessing nivolumab for metastatic uveal melanoma
Latest Information Update: 08 Feb 2022
At a glance
- Drugs Nivolumab (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 08 Feb 2022 New trial record